Chronic, recurrent Lymphocytic Leukemia Recruiting Phase 1 Trials for Cyclophosphamide (DB00531)

Also known as: Recurrent Chronic Lymphocytic Leukemia

IndicationStatusPhase
DBCOND0112002 (Chronic, recurrent Lymphocytic Leukemia)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02960646Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesTreatment
NCT04007029Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic LeukemiaTreatment